top of page

Technobis webinar: Controlling Polymorphic Impurities in Pharmaceutical Processes.

  • chromatechscientific
  • Apr 24
  • 2 min read

Updated: May 5

During this webinar, the guest speaker Jude Eames from Eurofins CDMO Alphora will present a case study on polymorphic impurities in the development of pharmaceutical processes.


Controlling Polymorphic Impurities in Pharmaceutical Processes


About the Webinar


In this webinar, guest speaker Jude Eames from Eurofins CDMO Alphora will share a case study on polymorphic impurities in pharmaceutical process development.


The case study highlights the importance of understanding polymorphic transitions to isolate a less thermodynamically stable polymorph. It also shows how the **Crystal16** and **Crystalline** were utilized to diagnose problems in the process.


Polymorphic impurities can be especially problematic. They are often undetectable in early stages. They may only surface later in development. This leads to process redesign and costly delays.


Key Insights


By attending, you will:


  • Gain practical insight into hidden risks in crystallization processes.

  • Understand how to identify and control trace polymorphic impurities.

  • Learn strategies for building a robust, reliable crystallization process.


Date and Time


  • Date: Tuesday, 12 May 2026

  • Time: 4.00 pm CEST | 3.00 pm GMT | 10.00 am EDT | 7.00 am PDT | 7.30 pm IST


Registration


**Register now** to secure your spot.


Guest Speaker


Jude Eames


Team Leader Solid-State Group at Eurofins CDMO Alphora


As a Team Leader in the Solid-State group at Eurofins CDMO Alphora, I have had the privilege of collaborating with a diverse range of clients and projects. I have over a decade of experience in characterizing materials and more than five years in pharmaceutical research. My focus is on ensuring robust processes that consistently deliver high-quality materials, overcoming unique challenges with innovative solutions. Outside of work, I enjoy spending time with my cat and playing Aussie Rules Football.


Conclusion


Understanding polymorphic impurities is crucial in pharmaceutical development. This webinar will provide valuable insights into managing these challenges effectively. Join us to enhance your knowledge and improve your processes.



For more information, visit our webinars page.

 
 
 

Recent Posts

See All

Comments


© 2024 by Chromatech Scientific Pty Ltd. 

bottom of page